- China Overseas Land reported a significant increase in contract sales for December, with a surge of 76.6%.
- The total contracted sales for December amounted to 40.23 billion yuan.
- The year-to-date contracted sales for the company reached 310.69 billion yuan.
- Analyst ratings for China Overseas Land include 30 buy recommendations, 3 hold recommendations, and no sell recommendations.
A look at China Overseas Land & Investment Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 4 | |
| Dividend | 4 | |
| Growth | 3 | |
| Resilience | 2 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 3.2 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Analysts at Smartkarma have given China Overseas Land & Investment a positive long-term outlook based on their Smart Scores. The company scored well in Value and Dividend factors, indicating strong fundamentals and potential for good returns. Although Growth scored slightly lower, China Overseas Land & Investment still maintains a decent overall outlook. However, the company scored lower on Resilience and Momentum, suggesting some areas that may need improvement to enhance its performance in the long run.
China Overseas Land & Investment Limited is a global real estate company that specializes in developing, managing, and investing in commercial properties. With solid ratings in Value and Dividend factors, the company demonstrates a strong foundation and potential for financial rewards. Despite facing challenges in Resilience and Momentum, China Overseas Land & Investment remains well-positioned to capitalize on opportunities in the real estate market, offering investors a promising long-term investment option.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
